Cervical Cancer Diagnostics market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By:Zion Market Research<br />
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong> - Global Industry<br />
Perspective, Comprehensive Analysis and Forecast<br />
2015-2021<br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zion<strong>market</strong>research.com
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong><br />
<strong>Cancer</strong> is a group of diseases involving abnormal growth of cells with the potential to spread to<br />
other parts of the body. There are various types of cancers affecting different parts of body.<br />
<strong>Cancer</strong> which develops in cervix is called cervical cancer. Two major types of cervical cancers<br />
diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of<br />
cervical cancer are caused by human papiloma virus (HPV). <strong>Cervical</strong> cancer is the third most<br />
common cancer among women and the second most frequent cause of cancer-related death,<br />
accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by Pap<br />
Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC). <strong>Cervical</strong> cancer is a<br />
sexually transmitted disease that can be prevented by early detection and vaccination.<br />
Browse “<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong>” Detail Report<br />
at https://www.zion<strong>market</strong>research.com/report/cervical-cancer-diagnostics-<strong>market</strong><br />
<strong>Cervical</strong> cancer diagnostics <strong>market</strong> is driven majorly by increasing percentage of HPV infected<br />
people across globe. HPV is an extremely common virus. According to the Centers for Disease
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong><br />
Control and Prevention (CDC), six million people in the United States acquire HPV each<br />
year. At least 20 million already have it, and more than half of all sexually-active adults are<br />
expected to be infected during their lifetime. Furthermore, rising awareness, literacy rate,<br />
government initiatives, government funding and various screening methods are expected to<br />
increase the growth of the <strong>market</strong> over the years. Moreover, many lifestyle-related factors, such<br />
as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV positive<br />
patients, are estimated to drive the cervical diagnostics <strong>market</strong> in the near future. However<br />
prevention of HPV by vaccination is major restraining factor in the growth of cervical cancer<br />
diagnostics <strong>market</strong>. In addition to this, the uncertain returning policy serves to be a major<br />
challenge impacting the growth of cervical cancer diagnostics <strong>market</strong>.<br />
Request Sample report at https://www.zion<strong>market</strong>research.com/sample/cervical-cancerdiagnostics-<strong>market</strong><br />
The report covers forecast and analysis of the cervical cancer diagnostics <strong>market</strong> on a global and<br />
regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021<br />
based on revenue (USD Million). To understand the competitive landscape in the <strong>market</strong>, an
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong><br />
analysis of Porter’s Five Forces model for the cervical cancer diagnostics <strong>market</strong> has also been<br />
included in the study. The report also analyzes several driving and restraining factors and their<br />
impact on the <strong>market</strong> during the forecast period. The study encompasses a <strong>market</strong> attractiveness<br />
analysis, wherein application segments are benchmarked based on their <strong>market</strong> size, growth<br />
rate and general attractiveness.<br />
The report provides detailed segmentation of the cervical cancer diagnostics <strong>market</strong> based on<br />
application and region. The regional <strong>market</strong> segment held the largest <strong>market</strong> share in 2015.<br />
Geographically, the <strong>market</strong> has been segmented into North America, Europe, Asia Pacific, Latin<br />
America, and Middle East & Africa. North America dominated the global cervical cancer<br />
diagnostic <strong>market</strong> in 2015 on account of the rising incidence of HPV infection, rising number of<br />
women smokers, and growing aged population. North America was followed by Europe in 2015.<br />
The <strong>market</strong> is expected to witness the growth in the Asia-Pacific region in the coming years due<br />
to the rising HPV infection in population, government initiative and availability of advance<br />
health care infrastructure.
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong><br />
Some of the key players contributing to the cervical cancer diagnostics <strong>market</strong> are Abbott<br />
Laboratories, Qiagen N.V., Hologic Inc., Roche <strong>Diagnostics</strong>, Quest <strong>Diagnostics</strong>, Becton,<br />
Dickinson and Company<br />
This report segments the cervical cancer diagnostics <strong>market</strong> are follows:-<br />
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> Market: Application Analysis<br />
<br />
<br />
<br />
Pap Smear Tests<br />
Colposcopy<br />
HPV Testing<br />
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> Market: Regional Analysis<br />
<br />
<br />
<br />
North America<br />
Europe<br />
Asia Pacific
<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong><br />
<br />
<br />
Latin America<br />
Middle East & Africa<br />
Browse “<strong>Cervical</strong> <strong>Cancer</strong> <strong>Diagnostics</strong> <strong>market</strong>” Detail Report<br />
at https://www.zion<strong>market</strong>research.com/report/cervical-cancer-diagnostics-<strong>market</strong><br />
Zion Market Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zion<strong>market</strong>research.comWeb:www.zion<strong>market</strong>research.com
Change language